Ono Pharmaceutical Co., Ltd. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Ono Pharmaceutical Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ono Pharmaceutical Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Ono Pharmaceutical Co., Ltd. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Ono Pharmaceutical Co., Ltd.
- Intelligence on Ono Pharmaceutical Co., Ltd.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ono Pharmaceutical Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Ono Pharmaceutical (Ono or ‘the company’) is primarily engaged in the manufacture and sale of pharmaceuticals. The company operates in Japan, other parts of Asia, Europe and the US. It is headquartered in Osaka, Japan, and employed 2,754 people as of March 31, 2012. The company recorded revenues of JPY145,779 million ($1,851.4 million*) during the financial year ended March 2012 (FY2012), an increase of 7.8% over FY2011. The operating profit of the company was JPY37,904 million ($481.4 million*) during FY2012, an increase of 7.7% over FY2011. The net profit was JPY24,361 million ($309.4 million*) in FY2012, an increase of 0.6% over FY2011. *Calculated using a constant conversion rate of JPY1 = $0.0127 for the financial year ended March 31, 2012.
Reasons to Purchase:
- Gain understanding of Ono Pharmaceutical Co., Ltd. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Ono Pharmaceutical Co., Ltd. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Ono Pharmaceutical Co., Ltd.’s business structure, strategy and prospects
Features:
- Detailed information on Ono Pharmaceutical Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ono Pharmaceutical Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Ono Pharmaceutical Co., Ltd. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Ono Pharmaceutical Co., Ltd.
- Intelligence on Ono Pharmaceutical Co., Ltd.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ono Pharmaceutical Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Ono Pharmaceutical (Ono or ‘the company’) is primarily engaged in the manufacture and sale of pharmaceuticals. The company operates in Japan, other parts of Asia, Europe and the US. It is headquartered in Osaka, Japan, and employed 2,754 people as of March 31, 2012. The company recorded revenues of JPY145,779 million ($1,851.4 million*) during the financial year ended March 2012 (FY2012), an increase of 7.8% over FY2011. The operating profit of the company was JPY37,904 million ($481.4 million*) during FY2012, an increase of 7.7% over FY2011. The net profit was JPY24,361 million ($309.4 million*) in FY2012, an increase of 0.6% over FY2011. *Calculated using a constant conversion rate of JPY1 = $0.0127 for the financial year ended March 31, 2012.
Reasons to Purchase:
- Gain understanding of Ono Pharmaceutical Co., Ltd. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Ono Pharmaceutical Co., Ltd. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Ono Pharmaceutical Co., Ltd.’s business structure, strategy and prospects
For more information, please visit:
Or email us at contact@aarkstore.com or call +919272852585
Aarkstore Enterprise
Tel : +912227453309
Mobile No:+08149852585
Email : contact@aarkstore.com
Website : http://www.aarkstore.com
No comments:
Post a Comment